Akoya Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Akoya Biosciences

09/08/2022 01:51

* Akoya Biosciences Inc  AKYA.OQ  reported a quarterly
adjusted
loss of 47 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 37 cents per share.
    * Revenue rose 36.9% to $17.89 million from a year ago;
analysts
expected $16.90 million. 
    * Akoya Biosciences Inc's reported EPS for the quarter was a
loss
of 47 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.6%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Akoya Biosciences Inc shares had risen by 14.9% this
quarter and
lost 3.6% so far this year.
    * The company reported a quarterly loss of $17.5 million.
    * Wall Street's median 12-month price target for Akoya
Biosciences
Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 12:51 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.37          -0.47          Missed
 Mar. 31 2022      -0.39          -0.44          Missed
 Dec. 31 2021      -0.31          -0.47          Missed
 Sep. 30 2021      -0.26          -0.31          Missed